References
-
Bae CS: Therapeutic effects of 1
$\alpha$ , 25 dihydroxycholecalciferol on osteoporotic fracture in a rat model. Korean J Vet Res 39(5): 974 985,1999, (Korean) - Bae CS, Park CH, Chang BJ, Kim HY, Cho IH, Uhm CS: Effects of safflower (Carthamus tinctorius L.) seed powder on bone resorption in ovariectomized rats, Korean J. Electron Microscopy 31(2): 109 116, 2001, (Korean)
- Baumgartner WA, Beck FWJ, Whitehouse MW: Adjuvant disease in rats : biochemical criteria for distinguishing several phases of inflammation and arthritis, Proc Soc exp BioI Med 145: 625 630, 1974 https://doi.org/10.3181/00379727-145-37863
- Binderup L: Decreased T suppressor cell activity in rats with adjuvant arthritis, Ann Rhewn Dis 42: 693 698,1983 https://doi.org/10.1136/ard.42.6.693
- Brandi ML: New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs, Am J Med 95(suppl 5A): 69 74, 1993 https://doi.org/10.1016/0002-9343(93)90386-4
-
Christiansen C, Christiansen MS, R
$\phi$ dbro P, Hagen C, Transb$\phi$ l I: Effect of 1,25 dihydroxyvitam in$D_3$ , in itself or combined with hormone treatment in preventing postmenopausal osteoporosis, Eur J Clin Invest 11(4): 305 309, 1981 https://doi.org/10.1111/j.1365-2362.1981.tb02121.x -
Endo K, Katsumata K, Hirata M, Ikeda K, Ogata E: 1,25 dihydroxyvitamin
$D_3$ , as well as its analogue OCT lower blood calcium through inhibition of bone resortion in hypercalcemic rats with continuous parathyroid hormone related peptide infusion, J Bone and Mineral Research 15(1): 175 181, 2000 https://doi.org/10.1359/jbmr.2000.15.1.175 - Erben RG, Bromm S, gtsngassinger M: Short term prophylaxis against estrogen depletion induced bone loss with calcitriol does not provide long term beneficial effects on cancellous bone mass or structure in ovariectomized rats, Osteoporos Int 8: 82 91, 1998a https://doi.org/10.1007/s001980050052
-
Erben RG, Bromm S, Stsngassinger M: Therapeutic efficacy of 1
$\alpha$ , 25 dihydroxyvitam in$D_3$ , and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effects of 1$\alpha$ , 25 dihydroxyvitamin$D_3$ , on bone, Endocrinology 139(10):4319 4328, 1998b https://doi.org/10.1210/en.139.10.4319 - Erben RG, Weiser H, Zucker H: Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats, Calcif Tissue Int 50(3): 228 236, 1992 https://doi.org/10.1007/BF00296287
-
Falch JA,
$\phi$ degaard OR, FinnangerAM, Matheson I: Postmenopausal osteoporosis: no effect of three years treatment with 1,25 dihydroxycholecalciferol. Acta Med Scand 221(2)',199 204,1987 https://doi.org/10.1111/j.0954-6820.1987.tb01267.x -
Gallagher JC, Jerpbak CM, Riggs BL: 1,25 dihydroxyvitamin
$D_3$ ,: Short and long term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis, Proc Natl Acad Sci USA 79 (10): 3325 3329, 1982 https://doi.org/10.1073/pnas.79.10.3325 -
Gallagher JC, Riggs BL: Action of 1,25 dihydroxyvitamin
$D_3$ , on calcium balance and bone turnover and its effect on vertebral fracture rate, Metabolism 39(4 Suppl 1): 30 34, 1990 - Gallagher JC, Riggs BL: Calcitriol for postmenopausal osteoporosis, Ann Intern Med 111(7): 621, 1989
- Gurlek A, Bayraktar M, Gedik O: Comparison of calcitriol treatment with etidronate calcitriol and calcitonin calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study, Calcif Tissue Int 61(1): 39 43, 1997 https://doi.org/10.1007/s002239900291
-
Haneji T, Kurihara N, Ikeda K, Kumegawa M: 1
$\alpha$ , 25 dihydroxyvitamin$D_3$ , induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria. J Biochem (Tokyo) 94(4): 1127 1132, 1983 https://doi.org/10.1093/oxfordjournals.jbchem.a134456 - Hauselmann HJ, Kramer E, Michel BA: Physical therapy in prevention and treatment of osteoporosis. Ther Umsch 55 (11):724 730, 1998
- Holick MF: Vitamin D and bone health. J Nutr 126(SuppI4): 1159 1164,1996 https://doi.org/10.1093/jn/126.suppl_4.1159S
- Ilich JZ, Badenhop NE, Nagode LA, Markovic V: Calcitriol and bone mass accumulation in females during puberty. Calcif Tissue Int 61(2): 104 109, 1997 https://doi.org/10.1007/s002239900304
-
Jensen GF, Meinecke B, Boesen J, Transbol I: Does 1,25
$(OH)_2D_3$ , accelerate spinal bone loss? A controlled therapeutic trial in 70 year old women, Clin Orthop 192: 215 221, 1985 - Lane JM, Nydick M: Osteoporosis: current modes of prevention and treatment. J Am Acad Orthop Surg 7 (1): 19 31, 1999 https://doi.org/10.5435/00124635-199901000-00003
-
Lindgren JU, Narechania RG, Lange TA, Deluca HF: Effects of 1,25 dihydroxyvitamin
$D_3$ , and calcitonin on fracture healing in adult rats, Clinical Orthopedics and Related Res 160:304 308, 1981 - Masud T, Mulcahy B, Keen RW, Doyle DV, Spector TO: Effects of cyclical etidronate combined with calcitrio l versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women, Annals of the Rheumatic Diseases 57 (6) : 346 349, 1998 https://doi.org/10.1136/ard.57.6.346
- Melton LJ, Atkinson EJ, O'Fallon WM, Riggs BL: Bone density and fracture risk in man, J Bone Miner Res 13(12) : 1915 1923, 1998 https://doi.org/10.1359/jbmr.1998.13.12.1915
- Morgan SL: Calcium and vitamin D in osteoporosis, Rheumatic Diseases Clinics of North America 27(1): 101 130, 2001 https://doi.org/10.1016/S0889-857X(05)70189-7
- O'Brien KO: Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women, Nutr Rev 56(5 Pt 1): 148 150, 1998 https://doi.org/10.1111/j.1753-4887.1998.tb01740.x
- Rosenthale ME, Capetola RJ: Adjuvant arthritis: immunopathological and hyperalgesic features, Fed Proc 41: 2577 2582, 1982
-
Shiraki M, Ito H, Orimo H: The effect of 1,25
$(OH)_2D_3$ , on bone mineral content in senile osteoporosis A dose finding study, Nippon Naibunpi Gakkai Zasshi 65 (11): 1253 1263, 1989 - Takagi T, Tsao PW, Totsuka R, Takata I: Changes in bone mineral density in rat adjuvant arthritis, Clinical Immuno l and Immunopathol 85(2) : 166 170, 1997 https://doi.org/10.1006/clin.1997.4417
-
Vukicevic S, Stavljenic A, Bagi C, Winter I: 1,25 dihydroxyvitamin
$D_3$ , stimulates alkaline phosphatase activity and inhibits soft tissue proliferation in implants of bone matrix, Clin Orthop 196 : 285 291, 1985 - Ziegler R: Drug treatment of osteoporosis, Ther Umsch 55(11): 696 701,1998